Literature DB >> 20826270

Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans.

Audrey C Au1, Paolo A Hernandez, Ernest Lieber, Ali M Nadroo, Yu-Ming Shen, Kevin A Kelley, Bruce D Gelb, George A Diaz.   

Abstract

The lymphatic vasculature is essential for the recirculation of extracellular fluid, fat absorption, and immune function and as a route of tumor metastasis. The dissection of molecular mechanisms underlying lymphangiogenesis has been accelerated by the identification of tissue-specific lymphatic endothelial markers and the study of congenital lymphedema syndromes. We report the results of genetic analyses of a kindred inheriting a unique autosomal-recessive lymphedema-choanal atresia syndrome. These studies establish linkage of the trait to chromosome 1q32-q41 and identify a loss-of-function mutation in PTPN14, which encodes a nonreceptor tyrosine phosphatase. The causal role of PTPN14 deficiency was confirmed by the generation of a murine Ptpn14 gene trap model that manifested lymphatic hyperplasia with lymphedema. Biochemical studies revealed a potential interaction between PTPN14 and the vascular endothelial growth factor receptor 3 (VEGFR3), a receptor tyrosine kinase essential for lymphangiogenesis. These results suggest a unique and conserved role for PTPN14 in the regulation of lymphatic development in mammals and a nonconserved role in choanal development in humans. 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826270      PMCID: PMC2933336          DOI: 10.1016/j.ajhg.2010.08.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  47 in total

1.  Choanal atresia and lymphedema.

Authors:  G Har-El; M L Borderon; M H Weiss
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-08       Impact factor: 1.547

2.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

Authors:  M Jeltsch; A Kaipainen; V Joukov; X Meng; M Lakso; H Rauvala; M Swartz; D Fukumura; R K Jain; K Alitalo
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

4.  Compensation for a gene trap mutation in the murine microtubule-associated protein 4 locus by alternative polyadenylation and alternative splicing.

Authors:  A K Voss; T Thomas; P Gruss
Journal:  Dev Dyn       Date:  1998-06       Impact factor: 3.780

5.  Efficiency assessment of the gene trap approach.

Authors:  A K Voss; T Thomas; P Gruss
Journal:  Dev Dyn       Date:  1998-06       Impact factor: 3.780

6.  Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping.

Authors:  B D Gelb; J G Edelson; R J Desnick
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

7.  Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains.

Authors:  A L Smith; P J Mitchell; J Shipley; B A Gusterson; M V Rogers; M R Crompton
Journal:  Biochem Biophys Res Commun       Date:  1995-04-26       Impact factor: 3.575

8.  Src kinase associates with a member of a distinct subfamily of protein-tyrosine phosphatases containing an ezrin-like domain.

Authors:  N P Møller; K B Møller; R Lammers; A Kharitonenkov; I Sures; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  Hereditary lymphedema: evidence for linkage and genetic heterogeneity.

Authors:  R E Ferrell; K L Levinson; J H Esman; M A Kimak; E C Lawrence; M M Barmada; D N Finegold
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

10.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Authors:  E Kukk; A Lymboussaki; S Taira; A Kaipainen; M Jeltsch; V Joukov; K Alitalo
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more
  30 in total

1.  Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.

Authors:  Panfeng Fu; Ramaswamy Ramchandran; Mark Shaaya; Longshuang Huang; David L Ebenezer; Ying Jiang; Yulia Komarova; Stephen M Vogel; Asrar B Malik; Richard D Minshall; Guangwei Du; Nicholas K Tonks; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2020-04-23       Impact factor: 5.157

2.  BMP-9 balances endothelial cell fate.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

3.  Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 Mutations.

Authors:  M Alders; A Mendola; L Adès; L Al Gazali; C Bellini; B Dallapiccola; P Edery; U Frank; F Hornshuh; S A Huisman; S Jagadeesh; H Kayserili; W T Keng; D Lev; C E Prada; J R Sampson; J Schmidtke; V Shashi; Y van Bever; N Van der Aa; J M Verhagen; J B Verheij; M Vikkula; R C Hennekam
Journal:  Mol Syndromol       Date:  2012-10-02

Review 4.  Development of the mammalian lymphatic vasculature.

Authors:  Ying Yang; Guillermo Oliver
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 5.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

6.  Hydrops fetalis and pulmonary lymphangiectasia due to FOXC2 mutation: an autosomal dominant hereditary lymphedema syndrome with variable expression.

Authors:  Gwendolyn de Bruyn; Alexandra Casaer; Katrien Devolder; Geert Van Acker; Hilde Logghe; Koen Devriendt; Luc Cornette
Journal:  Eur J Pediatr       Date:  2011-09-15       Impact factor: 3.183

7.  Molecular controls of lymphatic VEGFR3 signaling.

Authors:  Yong Deng; Xi Zhang; Michael Simons
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12-18       Impact factor: 8.311

8.  AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation.

Authors:  Elisa Boscolo; Silvia Coma; Valerie L Luks; Arin K Greene; Michael Klagsbrun; Matthew L Warman; Joyce Bischoff
Journal:  Angiogenesis       Date:  2014-11-26       Impact factor: 9.596

9.  Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia.

Authors:  Michael Benzinou; Frederic F Clermont; Tom G W Letteboer; Jai-Hyun Kim; Silvia Espejel; Kelly A Harradine; Juan Arbelaez; Minh Thu Luu; Ritu Roy; David Quigley; Mamie Nakayama Higgins; Musa Zaid; Bradley E Aouizerat; Johannes Kristian Ploos van Amstel; Sophie Giraud; Sophie Dupuis-Girod; Gaetan Lesca; Henri Plauchu; Christopher C W Hughes; Cornelius J J Westermann; Rosemary J Akhurst
Journal:  Nat Commun       Date:  2012-01-10       Impact factor: 14.919

Review 10.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.